Elacridar is an orally active P-glycoprotein (Pgp) and breast cancer resistance protein (BCRP) inhibitor. Elacridar can be used to examine the influence of efflux transporters on agent distribution to brain and the research of cancer[1][2]. 1 * 500 mg
Catalog # MDEXHY-50879
Supplier: MEDCHEMEXPRESS
Frequently Bought Together